Related Experiment Video
Updated: Sep 29, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Activation of macrophage nuclear factor-kappa B and induction of inducible nitric oxide synthase by LPS
Ying-Hua Li1, Zhong-Qun Yan, Annelie Brauner
1Astrid Lindgren Children's Hospital, Karolinska Institutet, Stockholm, Sweden. Ying-Hau.Li@kbh.ki.se
Insights
Lipopolysaccharide (LPS) stimulates nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression in macrophages. Steroids like dexamethasone and budesonide reduce these inflammatory responses, potentially explaining their benefit in chronic lung disease.
Area of Science:
- Neonatal immunology
- Pulmonary medicine
- Inflammation research
Background:
- Chronic lung disease (CLD) of prematurity is a significant neonatal care challenge.
- Bacterial infections and inflammation are implicated in CLD development.
- Steroids offer some therapeutic benefit in neonates with CLD.
Purpose of the Study:
- To investigate lipopolysaccharide (LPS)-induced nitric oxide (NO) production, inducible nitric oxide synthase (iNOS) expression, and nuclear factor-kappaB (NF-kappaB) activation in rat alveolar macrophages.
- To evaluate the effects of dexamethasone and budesonide on these LPS-induced responses in vitro.
Main Methods:
- Nitrite levels were measured using the Griess reaction.
- iNOS expression was assessed via Western blot and RT-PCR.
- NF-kappaB activation was analyzed using electrophoretic mobility shift assay (EMSA).
Main Results:
- LPS dose-dependently stimulated NO production in macrophages, an effect enhanced by IFN-gamma.
- Budesonide and dexamethasone significantly attenuated LPS-induced NO production and iNOS expression (mRNA and protein).
- LPS exposure triggered NF-kappaB activation, correlating with iNOS expression.
Conclusions:
- Gram-negative bacterial infection and associated inflammation are key factors in CLD pathogenesis.
- Steroids may benefit neonates with CLD by down-regulating iNOS expression and NO production.
- These findings elucidate a potential mechanism for steroid efficacy in neonatal lung disease.
Background:
Chronic lung disease (CLD) of prematurity is a major problem of neonatal care. Bacterial infection and inflammatory response have been thought to play an important role in the development of CLD and steroids have been given, with some benefit, to neonates with this disease. In the present study, we assessed the ability of lipopolysaccharide (LPS) to stimulate rat alveolar macrophages to produce nitric oxide (NO), express inducible nitric oxide synthase (iNOS) and activate nuclear factor-kappaB (NF-kappaB) in vitro. In addition, we investigated the impact of dexamethasone and budesonide on these processes.
Methods:
Griess reaction was used to measure the nitrite level. Western blot and a semi-quantitative RT-PCR were performed to detect iNOS expression. Electrophoretic mobility shift assay (EMSA) was performed to analyze the activation of NF-kappaB.
Results:
We found that LPS stimulated the rat alveolar macrophages to produce NO in a dose (>or=10 ng/ml) and time dependent manner (p < 0.05). This effect was further enhanced by IFN-gamma (>or=10 IU/ml, p < 0.05), but was attenuated by budesonide (10(-4)-10(-10) M) and dexamethasone (10(-4)-10(-6) M) (p < 0.05). The mRNA and protein levels of iNOS were also induced in response to LPS and attenuated by steroids. LPS triggered NF-kappaB activation, a mechanism responsible for the iNOS expression.
Conclusion:
Our findings imply that Gram-negative bacterial infection and the inflammatory responses are important factors in the development of CLD. The down-regulatory effect of steroids on iNOS expression and NO production might explain the beneficial effect of steroids in neonates with CLD.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Formation of Lipopolysaccharides
Nitric Oxide Signaling Pathway
Inflammation
Regulation of Nuclear Protein Sorting
Chronic Inflammation: Introduction

